TAZICEF

Product NDC
0409-5086
11-digit product format
004095086
Labeler code
0409
Product ID
0409-5086_b4cff5d5-d1ec-4959-b062-e754517aab2d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
CEFTAZIDIME
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Hospira, Inc.
Application
ANDA062662
Marketing category
ANDA
Marketing start
2006-04-20
Substance
CEFTAZIDIME
Active strength
6 g/1
Pharmacologic classes
Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
TAZICEF
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CEFTAZIDIME6 g/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii9M416Z9QNR
Rxcui206423, 242800

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fb7d24f2-fcd1-4dc6-b9d0-b1f65bfffab5Product name120150409

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0409-5086-11TAZICEF10 in 1 CARTONINJECTION, POWDER, FOR SOLUTION1030
0409-5086-13TAZICEF1 in 1 VIAL, PHARMACY BULK PACKAGEINJECTION, POWDER, FOR SOLUTION130

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0409-5086-11EA - Each0409-5086a426c9bf-d465-4e91-b452-1d7be5b9d89a12012-07-24
0409-5086-13EA - Each0409-5086da06540c-7345-40c6-b234-b3ec96e8316112022-12-07
0409-5086-51EA - Each0409-508648d68fd7-2cf4-46e7-8174-fd1eaf54e08b12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CEFTAZIDIMEACTIVE INGREDIENT9M416Z9QNRTAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]13
CEFTAZIDIME ANHYDROUSACTIVE MOIETYDZR1ENT301TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]13
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TTAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0409-5086TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]30Current NDC, Legacy NDC, 2 package rows20240705_1ab5ae3e-e303-4499-4c89-472d7cc1e46c.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
242800cefTAZidime 200 MG/ML Injectable SolutionPSN1ab5ae3e-e303-4499-4c89-472d7cc1e46c30
206423Tazicef 200 MG/ML Injectable SolutionPSN1ab5ae3e-e303-4499-4c89-472d7cc1e46c30
206423ceftazidime 200 MG/ML Injectable Solution [Tazicef]SBD1ab5ae3e-e303-4499-4c89-472d7cc1e46c30
242800ceftazidime 200 MG/ML Injectable SolutionSCD1ab5ae3e-e303-4499-4c89-472d7cc1e46c30
242800ceftazidime 200 MG/ML Concentrate for Injectable SolutionSY1ab5ae3e-e303-4499-4c89-472d7cc1e46c30
242800ceftazidime 6 GM per 30 ML Injectable SolutionSY1ab5ae3e-e303-4499-4c89-472d7cc1e46c30
206423Tazicef 200 MG/ML Injectable SolutionSY1ab5ae3e-e303-4499-4c89-472d7cc1e46c30

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0409-5086-110040950861110 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (0409-5086-11) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PHARMACY BULK PACKAGE (0409-5086-13) 2006-04-200000-00-00NoNoCurrent
0409-5086-13004095086131 in 1 VIAL, PHARMACY BULK PACKAGEHistorical